Skip to main content
x
Dartmouth-Hitchcock logo
Summer Flowers In This Section
 
A Phase 2 Dose Ranging, Randomized, Double Blind, Placebocontrolled Study Evaluating The Safety, Tolerability, Pharmacokinetics And Efficacy Of EDP-305 In Subjects With Primary Biliary Cholangitis (PBC) With Or Without An Inadequate Response To Ursodeoxycholic Acid (UDCA)
Principal Investigator (?)
Study Number
F18136
Summary
A randomized, double-blind study to assess the safety, tolerability, PK and efficacy of EDP-305 in subjects with primary biliary cholangitis 
Phase (?)
Phase III
Sponsor (?)
Contact

Jessica Chevalier

Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

0